Parkinson disease Parkinsonism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with the clinical findings consistent with idiopathic Parkinson Disease (PD) and who suffer from severe response fluctuations and/or dyskinesias, despite optimal drug treatment, who are candidates for DBS.
Exclusion criteria
Exclusion criteria: Those PD patients suffering from severe psychiatric co-morbidities and cognitive decline, e.g. dementia and psychosis, are excluded from this study. The mini mental state exam (MMSE) score is not allowed to be
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| There are two main endpoints to measure the feasibility. First, the patients burden and outcome. We will interview the patient and ask him to fill in a standardized questionnaire. Only if the burden is acceptable, we will start with the main study (average marks for each testing must be above 5 to continue with a RCT). Thereby the motor symptoms must be significantly less pronounced with stimulation than pre-operatively. Secondly, the technical feasibility depends on the possibility to register the potentials, evoked by motor cortex stimulation in the STN (so-called evoked potentials). These potentials have to be clearly identifiable in order to recognize the motor part of the STN. This is necessary as in the final study we want to compare the results of selective stimulation of the motor part of the STN with results of the classical procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognition, and in particular impulsivity, and affect, will be assessed by neuropsychological testing and a self-report questionnaire, the Positive and Negative Affect Scale (Watson et al 1988). Neuropsychological testing covers the main cognitive domains but the study parameters are related to the performance on tasks in the relevant domain of executive functioning, including word fluency, the Stroop (Lezak, 2004), a finger precuing task (Adam et al, 2002) and the Iowa Gambling Task (Bechera et al., 1994). (These are not endpoints of the feasibility trial.) Advantage of fMRI above TMS or double contrast MRI in the planning of the OR. | — |
Countries
Netherlands